{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:29:55Z","timestamp":1788809395909,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T00:00:00Z","timestamp":1713052800000},"content-version":"am","delay-in-days":288,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014276","name":"Pershing Square Sohn Cancer Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972034"],"award-info":[{"award-number":["81972034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92068104"],"award-info":[{"award-number":["92068104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2022J06003"],"award-info":[{"award-number":["2022J06003"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2T32AR071302-07"],"award-info":[{"award-number":["2T32AR071302-07"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR075585"],"award-info":[{"award-number":["R01AR075585"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR078230"],"award-info":[{"award-number":["R01AR078230"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R21AR077557"],"award-info":[{"award-number":["R21AR077557"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bone.2023.116761","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T21:33:17Z","timestamp":1680816797000},"page":"116761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["An angiogenic approach to osteoanabolic therapy targeting the SHN3-SLIT3 pathway"],"prefix":"10.1016","volume":"172","author":[{"given":"Alisha R.","family":"Yallowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyuck","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2023.116761_bb0005","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2023.116761_bb0010","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1210\/clinem\/dgab193","article-title":"Cardiovascular safety and sclerostin inhibition","volume":"106","author":"Langdahl","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2023.116761_bb0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jcph.239","article-title":"Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study","volume":"54","author":"Padhi","year":"2014","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2023.116761_bb0020","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2023.116761_bb0025","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2023.116761_bb0030","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","article-title":"Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-switch study): extension of a randomised controlled trial","volume":"386","author":"Leder","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bone.2023.116761_bb0035","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1210\/jc.2016-1160","article-title":"Effects of two years of teriparatide, denosumab, or both on bone microarchitecture and strength (DATA-HRpQCT study)","volume":"101","author":"Tsai","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2023.116761_bb0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(13)60856-9","article-title":"Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial","volume":"382","author":"Tsai","year":"2013","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bone.2023.116761_bb0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbmr.2315","article-title":"Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT study","volume":"30","author":"Tsai","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2023.116761_bb0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2172-3-10","article-title":"The kappa B transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3\/KRC: a site selection amplification binding study","volume":"3","author":"Allen","year":"2002","journal-title":"BMC Immunol."},{"key":"10.1016\/j.bone.2023.116761_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20030421","article-title":"Schnurri-3 (KRC) interacts with c-Jun to regulate the IL-2 gene in T cells","volume":"199","author":"Oukka","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bone.2023.116761_bb0060","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/nar\/27.2.643","article-title":"Regulation by phosphorylation of the zinc finger protein KRC that binds the kappaB motif and V(D)J recombination signal sequences","volume":"27","author":"Bachmeyer","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bone.2023.116761_bb0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s002510050397","article-title":"KRC transcripts: identification of an unusual alternative splicing event","volume":"48","author":"Mak","year":"1998","journal-title":"Immunogenetics"},{"key":"10.1016\/j.bone.2023.116761_bb0070","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1126\/science.1126313","article-title":"Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3","volume":"312","author":"Jones","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bone.2023.116761_bb0075","doi-asserted-by":"crossref","first-page":"12907","DOI":"10.1074\/jbc.M611203200","article-title":"Lack of Schnurri-2 expression associates with reduced bone remodeling and osteopenia","volume":"282","author":"Saita","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2023.116761_bb0080","doi-asserted-by":"crossref","first-page":"8254","DOI":"10.1073\/pnas.1003727107","article-title":"Uncoupling of growth plate maturation and bone formation in mice lacking both Schnurri-2 and Schnurri-3","volume":"107","author":"Jones","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2023.116761_bb0085","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1172\/JCI69443","article-title":"Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts","volume":"123","author":"Shim","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2023.116761_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-018-0020-z","article-title":"Targeting skeletal endothelium to ameliorate bone loss","author":"Xu","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2023.116761_bb0095","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1073\/pnas.1205848109","article-title":"Control of bone resorption in mice by Schnurri-3","volume":"109","author":"Wein","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2023.116761_bb0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0898-6568(02)00112-2","article-title":"Molecular recognitions in the MAP kinase cascades","volume":"15","author":"Tanoue","year":"2003","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bone.2023.116761_bb0105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/35000065","article-title":"A conserved docking motif in MAP kinases common to substrates, activators and regulators","volume":"2","author":"Tanoue","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bone.2023.116761_bb0110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1083\/jcb.200610046","article-title":"Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development","volume":"176","author":"Ge","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bone.2023.116761_bb0115","article-title":"The ERK MAPK pathway is essential for skeletal development and homeostasis","volume":"20","author":"Kim","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2023.116761_bb0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-cellbio-101512-122347","article-title":"Mitogen-activated protein kinase pathways in osteoblasts","volume":"29","author":"Greenblatt","year":"2013","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bone.2023.116761_bb0125","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jbmr.561","article-title":"Interactions between extracellular signal-regulated kinase 1\/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity","volume":"27","author":"Ge","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2023.116761_bb0130","doi-asserted-by":"crossref","first-page":"32533","DOI":"10.1074\/jbc.M109.040980","article-title":"Identification and functional characterization of ERK\/MAPK phosphorylation sites in the Runx2 transcription factor","volume":"284","author":"Ge","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2023.116761_bb0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbrc.2020.07.060","article-title":"TAOK3 is a MAP3K contributing to osteoblast differentiation and skeletal mineralization","volume":"531","author":"Li","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2023.116761_bb0140","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78069","article-title":"Biphasic regulation of osteoblast development via the ERK MAPK-mTOR pathway","volume":"11","author":"Kim","year":"2022","journal-title":"elife"},{"key":"10.1016\/j.bone.2023.116761_bb0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2006.10.010","article-title":"ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae","volume":"4","author":"Elefteriou","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bone.2023.116761_bb0150","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1038\/s41467-019-10809-6","article-title":"Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2023.116761_bb0155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature13146","article-title":"Endothelial notch activity promotes angiogenesis and osteogenesis in bone","volume":"507","author":"Ramasamy","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bone.2023.116761_bb0160","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature13145","article-title":"Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone","volume":"507","author":"Kusumbe","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bone.2023.116761_bb0165","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.1523\/JNEUROSCI.1479-07.2007","article-title":"Dual branch-promoting and branch-repelling actions of Slit\/Robo signaling on peripheral and central branches of developing sensory axons","volume":"27","author":"Ma","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bone.2023.116761_bb0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-0-387-76715-4_5","article-title":"Slits and their receptors","volume":"621","author":"Ch\u00e9dotal","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bone.2023.116761_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172736","article-title":"Expression patterns of slit and robo family members in adult mouse spinal cord and peripheral nervous system","volume":"12","author":"Carr","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2023.116761_bb0180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.3849","article-title":"Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization","volume":"21","author":"Rama","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2023.116761_bb0185","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.devcel.2010.12.001","article-title":"Robo4 maintains vessel integrity and inhibits angiogenesis by interacting with UNC5B","volume":"20","author":"Koch","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bone.2023.116761_bb0190","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI91086","article-title":"Osteoclast-secreted SLIT3 coordinates bone resorption and formation","volume":"128","author":"Kim","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2023.116761_bb0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41413-020-0086-3","article-title":"Osteoclasts are not a source of SLIT3","volume":"8","author":"Li","year":"2020","journal-title":"Bone Res."},{"key":"10.1016\/j.bone.2023.116761_bb0200","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.2489","article-title":"Suppression of bone formation by osteoclastic expression of semaphorin 4D","volume":"17","author":"Negishi-Koga","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2023.116761_bb0205","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI82585","article-title":"Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair","volume":"126","author":"Hu","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2023.116761_bb0210","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1038\/s41598-017-13417-w","article-title":"Vascular endothelial growth factor in cartilage development and osteoarthritis","volume":"7","author":"Nagao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2023.116761_bb0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0070-2153(04)65006-X","article-title":"Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair","volume":"65","author":"Zelzer","year":"2005","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.bone.2023.116761_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.5.2.10","article-title":"VEGF and intraocular neovascularization: from discovery to therapy","volume":"5","author":"Ferrara","year":"2016","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.bone.2023.116761_bb0225","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm.1877","article-title":"Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma","volume":"14","author":"Jinnin","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2023.116761_bb0230","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MOH.0b013e32832a07ff","article-title":"Signaling mechanisms in infantile hemangioma","volume":"16","author":"Boye","year":"2009","journal-title":"Curr. Opin. Hematol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223000947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223000947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:06:16Z","timestamp":1757613976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328223000947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":46,"alternative-id":["S8756328223000947"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2023.116761","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An angiogenic approach to osteoanabolic therapy targeting the SHN3-SLIT3 pathway","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2023.116761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116761"}}